On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...